世界のヒト化抗体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Antibody Humanization Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0373 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ヒト化抗体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、二重特異性抗体、CDRグラフト化抗体）、用途別市場規模（HIV、SARS、RSV、プリオン）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ヒト化抗体の市場動向 ・企業の競争状況、市場シェア ・ヒト化抗体の種類別市場規模（モノクローナル抗体、二重特異性抗体、CDRグラフト化抗体） ・ヒト化抗体の用途別市場規模（HIV、SARS、RSV、プリオン） ・ヒト化抗体の北米市場規模2016-2027（アメリカ、カナダ） ・ヒト化抗体のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒト化抗体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒト化抗体の中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒト化抗体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Accurus Biosciences、IONTAS、Lonza、Oak BioSciences、Panorama Research、PX'Therapeutics、Yurogen Biosystems） ・結論

Market Analysis and Insights: Global Antibody Humanization Market
The global Antibody Humanization market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antibody Humanization market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antibody Humanization market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antibody Humanization market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antibody Humanization market.

Global Antibody Humanization Scope and Market Size
Antibody Humanization market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antibody Humanization market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Monoclonal Antibodies
Bispecific Antibodies
CDR Grafted Antibodies

Segment by Application
HIV
SARS
RSV
Prion

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Accurus Biosciences
IONTAS
Lonza
Oak BioSciences
Panorama Research
PX’Therapeutics
Yurogen Biosystems

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Humanization Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Monoclonal Antibodies
1.2.3 Bispecific Antibodies
1.2.4 CDR Grafted Antibodies
1.3 Market by Application
1.3.1 Global Antibody Humanization Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 HIV
1.3.3 SARS
1.3.4 RSV
1.3.5 Prion
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antibody Humanization Market Perspective (2016-2027)
2.2 Antibody Humanization Growth Trends by Regions
2.2.1 Antibody Humanization Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antibody Humanization Historic Market Share by Regions (2016-2021)
2.2.3 Antibody Humanization Forecasted Market Size by Regions (2022-2027)
2.3 Antibody Humanization Industry Dynamic
2.3.1 Antibody Humanization Market Trends
2.3.2 Antibody Humanization Market Drivers
2.3.3 Antibody Humanization Market Challenges
2.3.4 Antibody Humanization Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antibody Humanization Players by Revenue
3.1.1 Global Top Antibody Humanization Players by Revenue (2016-2021)
3.1.2 Global Antibody Humanization Revenue Market Share by Players (2016-2021)
3.2 Global Antibody Humanization Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antibody Humanization Revenue
3.4 Global Antibody Humanization Market Concentration Ratio
3.4.1 Global Antibody Humanization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Humanization Revenue in 2020
3.5 Antibody Humanization Key Players Head office and Area Served
3.6 Key Players Antibody Humanization Product Solution and Service
3.7 Date of Enter into Antibody Humanization Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antibody Humanization Breakdown Data by Type
4.1 Global Antibody Humanization Historic Market Size by Type (2016-2021)
4.2 Global Antibody Humanization Forecasted Market Size by Type (2022-2027)

5 Antibody Humanization Breakdown Data by Application
5.1 Global Antibody Humanization Historic Market Size by Application (2016-2021)
5.2 Global Antibody Humanization Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antibody Humanization Market Size (2016-2027)
6.2 North America Antibody Humanization Market Size by Type
6.2.1 North America Antibody Humanization Market Size by Type (2016-2021)
6.2.2 North America Antibody Humanization Market Size by Type (2022-2027)
6.2.3 North America Antibody Humanization Market Size by Type (2016-2027)
6.3 North America Antibody Humanization Market Size by Application
6.3.1 North America Antibody Humanization Market Size by Application (2016-2021)
6.3.2 North America Antibody Humanization Market Size by Application (2022-2027)
6.3.3 North America Antibody Humanization Market Size by Application (2016-2027)
6.4 North America Antibody Humanization Market Size by Country
6.4.1 North America Antibody Humanization Market Size by Country (2016-2021)
6.4.2 North America Antibody Humanization Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Antibody Humanization Market Size (2016-2027)
7.2 Europe Antibody Humanization Market Size by Type
7.2.1 Europe Antibody Humanization Market Size by Type (2016-2021)
7.2.2 Europe Antibody Humanization Market Size by Type (2022-2027)
7.2.3 Europe Antibody Humanization Market Size by Type (2016-2027)
7.3 Europe Antibody Humanization Market Size by Application
7.3.1 Europe Antibody Humanization Market Size by Application (2016-2021)
7.3.2 Europe Antibody Humanization Market Size by Application (2022-2027)
7.3.3 Europe Antibody Humanization Market Size by Application (2016-2027)
7.4 Europe Antibody Humanization Market Size by Country
7.4.1 Europe Antibody Humanization Market Size by Country (2016-2021)
7.4.2 Europe Antibody Humanization Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antibody Humanization Market Size (2016-2027)
8.2 Asia-Pacific Antibody Humanization Market Size by Type
8.2.1 Asia-Pacific Antibody Humanization Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antibody Humanization Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antibody Humanization Market Size by Type (2016-2027)
8.3 Asia-Pacific Antibody Humanization Market Size by Application
8.3.1 Asia-Pacific Antibody Humanization Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antibody Humanization Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antibody Humanization Market Size by Application (2016-2027)
8.4 Asia-Pacific Antibody Humanization Market Size by Region
8.4.1 Asia-Pacific Antibody Humanization Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antibody Humanization Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antibody Humanization Market Size (2016-2027)
9.2 Latin America Antibody Humanization Market Size by Type
9.2.1 Latin America Antibody Humanization Market Size by Type (2016-2021)
9.2.2 Latin America Antibody Humanization Market Size by Type (2022-2027)
9.2.3 Latin America Antibody Humanization Market Size by Type (2016-2027)
9.3 Latin America Antibody Humanization Market Size by Application
9.3.1 Latin America Antibody Humanization Market Size by Application (2016-2021)
9.3.2 Latin America Antibody Humanization Market Size by Application (2022-2027)
9.3.3 Latin America Antibody Humanization Market Size by Application (2016-2027)
9.4 Latin America Antibody Humanization Market Size by Country
9.4.1 Latin America Antibody Humanization Market Size by Country (2016-2021)
9.4.2 Latin America Antibody Humanization Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antibody Humanization Market Size (2016-2027)
10.2 Middle East & Africa Antibody Humanization Market Size by Type
10.2.1 Middle East & Africa Antibody Humanization Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antibody Humanization Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antibody Humanization Market Size by Type (2016-2027)
10.3 Middle East & Africa Antibody Humanization Market Size by Application
10.3.1 Middle East & Africa Antibody Humanization Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antibody Humanization Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antibody Humanization Market Size by Application (2016-2027)
10.4 Middle East & Africa Antibody Humanization Market Size by Country
10.4.1 Middle East & Africa Antibody Humanization Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antibody Humanization Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Accurus Biosciences
11.1.1 Accurus Biosciences Company Details
11.1.2 Accurus Biosciences Business Overview
11.1.3 Accurus Biosciences Antibody Humanization Introduction
11.1.4 Accurus Biosciences Revenue in Antibody Humanization Business (2016-2021)
11.1.5 Accurus Biosciences Recent Development
11.2 IONTAS
11.2.1 IONTAS Company Details
11.2.2 IONTAS Business Overview
11.2.3 IONTAS Antibody Humanization Introduction
11.2.4 IONTAS Revenue in Antibody Humanization Business (2016-2021)
11.2.5 IONTAS Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Antibody Humanization Introduction
11.3.4 Lonza Revenue in Antibody Humanization Business (2016-2021)
11.3.5 Lonza Recent Development
11.4 Oak BioSciences
11.4.1 Oak BioSciences Company Details
11.4.2 Oak BioSciences Business Overview
11.4.3 Oak BioSciences Antibody Humanization Introduction
11.4.4 Oak BioSciences Revenue in Antibody Humanization Business (2016-2021)
11.4.5 Oak BioSciences Recent Development
11.5 Panorama Research
11.5.1 Panorama Research Company Details
11.5.2 Panorama Research Business Overview
11.5.3 Panorama Research Antibody Humanization Introduction
11.5.4 Panorama Research Revenue in Antibody Humanization Business (2016-2021)
11.5.5 Panorama Research Recent Development
11.6 PX’Therapeutics
11.6.1 PX’Therapeutics Company Details
11.6.2 PX’Therapeutics Business Overview
11.6.3 PX’Therapeutics Antibody Humanization Introduction
11.6.4 PX’Therapeutics Revenue in Antibody Humanization Business (2016-2021)
11.6.5 PX’Therapeutics Recent Development
11.7 Yurogen Biosystems
11.7.1 Yurogen Biosystems Company Details
11.7.2 Yurogen Biosystems Business Overview
11.7.3 Yurogen Biosystems Antibody Humanization Introduction
11.7.4 Yurogen Biosystems Revenue in Antibody Humanization Business (2016-2021)
11.7.5 Yurogen Biosystems Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antibody Humanization Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Bispecific Antibodies
Table 4. Key Players of CDR Grafted Antibodies
Table 5. Global Antibody Humanization Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Antibody Humanization Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Antibody Humanization Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Antibody Humanization Market Share by Regions (2016-2021)
Table 9. Global Antibody Humanization Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Antibody Humanization Market Share by Regions (2022-2027)
Table 11. Antibody Humanization Market Trends
Table 12. Antibody Humanization Market Drivers
Table 13. Antibody Humanization Market Challenges
Table 14. Antibody Humanization Market Restraints
Table 15. Global Antibody Humanization Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Antibody Humanization Market Share by Players (2016-2021)
Table 17. Global Top Antibody Humanization Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Humanization as of 2020)
Table 18. Ranking of Global Top Antibody Humanization Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Antibody Humanization Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antibody Humanization Product Solution and Service
Table 22. Date of Enter into Antibody Humanization Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antibody Humanization Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Antibody Humanization Revenue Market Share by Type (2016-2021)
Table 26. Global Antibody Humanization Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Antibody Humanization Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Antibody Humanization Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Antibody Humanization Revenue Market Share by Application (2016-2021)
Table 30. Global Antibody Humanization Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Antibody Humanization Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Antibody Humanization Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Antibody Humanization Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Antibody Humanization Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Antibody Humanization Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Antibody Humanization Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Antibody Humanization Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Antibody Humanization Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Antibody Humanization Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Antibody Humanization Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Antibody Humanization Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Antibody Humanization Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Antibody Humanization Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Antibody Humanization Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Antibody Humanization Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Antibody Humanization Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Antibody Humanization Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Antibody Humanization Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Antibody Humanization Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Antibody Humanization Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Antibody Humanization Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Antibody Humanization Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Antibody Humanization Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Antibody Humanization Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Antibody Humanization Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Antibody Humanization Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Antibody Humanization Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Antibody Humanization Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Antibody Humanization Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Antibody Humanization Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Antibody Humanization Market Size by Country (2022-2027) & (US$ Million)
Table 62. Accurus Biosciences Company Details
Table 63. Accurus Biosciences Business Overview
Table 64. Accurus Biosciences Antibody Humanization Product
Table 65. Accurus Biosciences Revenue in Antibody Humanization Business (2016-2021) & (US$ Million)
Table 66. Accurus Biosciences Recent Development
Table 67. IONTAS Company Details
Table 68. IONTAS Business Overview
Table 69. IONTAS Antibody Humanization Product
Table 70. IONTAS Revenue in Antibody Humanization Business (2016-2021) & (US$ Million)
Table 71. IONTAS Recent Development
Table 72. Lonza Company Details
Table 73. Lonza Business Overview
Table 74. Lonza Antibody Humanization Product
Table 75. Lonza Revenue in Antibody Humanization Business (2016-2021) & (US$ Million)
Table 76. Lonza Recent Development
Table 77. Oak BioSciences Company Details
Table 78. Oak BioSciences Business Overview
Table 79. Oak BioSciences Antibody Humanization Product
Table 80. Oak BioSciences Revenue in Antibody Humanization Business (2016-2021) & (US$ Million)
Table 81. Oak BioSciences Recent Development
Table 82. Panorama Research Company Details
Table 83. Panorama Research Business Overview
Table 84. Panorama Research Antibody Humanization Product
Table 85. Panorama Research Revenue in Antibody Humanization Business (2016-2021) & (US$ Million)
Table 86. Panorama Research Recent Development
Table 87. PX'Therapeutics Company Details
Table 88. PX'Therapeutics Business Overview
Table 89. PX'Therapeutics Antibody Humanization Product
Table 90. PX'Therapeutics Revenue in Antibody Humanization Business (2016-2021) & (US$ Million)
Table 91. PX'Therapeutics Recent Development
Table 92. Yurogen Biosystems Company Details
Table 93. Yurogen Biosystems Business Overview
Table 94. Yurogen Biosystems Antibody Humanization Product
Table 95. Yurogen Biosystems Revenue in Antibody Humanization Business (2016-2021) & (US$ Million)
Table 96. Yurogen Biosystems Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibody Humanization Market Share by Type: 2020 VS 2027
Figure 2. Monoclonal Antibodies Features
Figure 3. Bispecific Antibodies Features
Figure 4. CDR Grafted Antibodies Features
Figure 5. Global Antibody Humanization Market Share by Application: 2020 VS 2027
Figure 6. HIV Case Studies
Figure 7. SARS Case Studies
Figure 8. RSV Case Studies
Figure 9. Prion Case Studies
Figure 10. Antibody Humanization Report Years Considered
Figure 11. Global Antibody Humanization Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Antibody Humanization Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Antibody Humanization Market Share by Regions: 2020 VS 2027
Figure 14. Global Antibody Humanization Market Share by Regions (2022-2027)
Figure 15. Global Antibody Humanization Market Share by Players in 2020
Figure 16. Global Top Antibody Humanization Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibody Humanization as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Antibody Humanization Revenue in 2020
Figure 18. Global Antibody Humanization Revenue Market Share by Type (2016-2021)
Figure 19. Global Antibody Humanization Revenue Market Share by Type (2022-2027)
Figure 20. North America Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Antibody Humanization Market Share by Type (2016-2027)
Figure 22. North America Antibody Humanization Market Share by Application (2016-2027)
Figure 23. North America Antibody Humanization Market Share by Country (2016-2027)
Figure 24. United States Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Antibody Humanization Market Share by Type (2016-2027)
Figure 28. Europe Antibody Humanization Market Share by Application (2016-2027)
Figure 29. Europe Antibody Humanization Market Share by Country (2016-2027)
Figure 30. Germany Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Antibody Humanization Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Antibody Humanization Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Antibody Humanization Market Share by Region (2016-2027)
Figure 40. China Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Antibody Humanization Market Share by Type (2016-2027)
Figure 48. Latin America Antibody Humanization Market Share by Application (2016-2027)
Figure 49. Latin America Antibody Humanization Market Share by Country (2016-2027)
Figure 50. Mexico Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Antibody Humanization Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Antibody Humanization Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Antibody Humanization Market Share by Country (2016-2027)
Figure 56. Turkey Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Antibody Humanization Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Accurus Biosciences Revenue Growth Rate in Antibody Humanization Business (2016-2021)
Figure 60. IONTAS Revenue Growth Rate in Antibody Humanization Business (2016-2021)
Figure 61. Lonza Revenue Growth Rate in Antibody Humanization Business (2016-2021)
Figure 62. Oak BioSciences Revenue Growth Rate in Antibody Humanization Business (2016-2021)
Figure 63. Panorama Research Revenue Growth Rate in Antibody Humanization Business (2016-2021)
Figure 64. PX'Therapeutics Revenue Growth Rate in Antibody Humanization Business (2016-2021)
Figure 65. Yurogen Biosystems Revenue Growth Rate in Antibody Humanization Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---